Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Imugene Limited (IUGNF)
OTHER OTC:IUGNF
Imugene Limited (IUGNF) Stock Price & Analysis
16 Followers
IUGNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.14
Previous Close$0.07
Volume104.96K
Average Volume (3M)202.66K
Market Cap
$478.35M
Enterprise Value$411.54M
Total Cash (Recent Filing)AU$99.89M
Total Debt (Recent Filing)AU$673.43K
Price to Earnings (P/E)-16.8
Beta0.99
Next Earnings
Feb 28, 2024Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding7,164,974,859
10 Day Avg. Volume206,745
30 Day Avg. Volume202,662
Standard Deviation0.72
R-Squared0.14
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
8.70% Insiders
2.35% Mutual Funds
3.61% Other Institutional Investors
85.34% Public Companies and
Individual Investors
IUGNF FAQ
What was Imugene Limited’s price range in the past 12 months?
Imugene Limited lowest stock price was $0.02 and its highest was $0.14 in the past 12 months.
What is Imugene Limited’s market cap?
Currently, no data Available
When is Imugene Limited’s upcoming earnings report date?
Imugene Limited’s upcoming earnings report date is Feb 28, 2024 which is in 86 days.
How were Imugene Limited’s earnings last quarter?
Imugene Limited released its earnings results on Aug 25, 2023. The company reported $0 earnings per share for the quarter, the consensus estimate of $0 by $0.
Is Imugene Limited overvalued?
According to Wall Street analysts Imugene Limited’s price is currently Overvalued.
Does Imugene Limited pay dividends?
Imugene Limited does not currently pay dividends.
What is Imugene Limited’s EPS estimate?
Imugene Limited’s EPS estimate is $0.
How many shares outstanding does Imugene Limited have?
Imugene Limited has 7,164,975,000 shares outstanding.
What happened to Imugene Limited’s price movement after its last earnings report?
Imugene Limited reported an EPS of $0 in its last earnings report, expectations of $0. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Imugene Limited?
Currently, no hedge funds are holding shares in IUGNF
---
Imugene Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
IUGNF Sentiment 91%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $349.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.80%
12-Months-Change
Fundamentals
Return on Equity
-23.03%
Trailing 12-Months
Asset Growth
29.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Imugene Limited
Imugene Ltd specializes is a clinical-stage immuno-oncology company. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being Research, Development, and Commercialisation of oncolytic immunotherapies.
---
---